| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/29/2008 | US20080125438 2-aminothiophene derivatives; {2-Amino-4-[(4-phenylpiperazin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic for chronic neuropathic pain, cardiac disarrhythmias, angina; neurological disease or injury, sleep disorder, epilepsy, antidepressants |
| 05/29/2008 | US20080125427 Novel Inhibitors of Rho-Kinases |
| 05/29/2008 | US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 05/29/2008 | US20080125422 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125416 Sigma Receptor Inhibitors |
| 05/29/2008 | US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 05/29/2008 | US20080125385 Decreasing activity improves beta-adrenergic response; point mutations; gene expression inhibition |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124416 Therapeutic composition from goji (lycium barbarum l.), methods of making and using |
| 05/29/2008 | US20080124407 Inhibiting cyp3a4 induction |
| 05/29/2008 | US20080124404 reducing at least one of total cholesterol, LDL-cholesterol, free fatty acids, or triglycerides; composition comprising berberine or a pharmaceutically acceptable salt thereof and a multi-drug resistant pump (MDR) inhibitor |
| 05/29/2008 | US20080124401 Method of treating endothelial injury |
| 05/29/2008 | US20080124374 Decellularized bone marrow extracellular matrix |
| 05/29/2008 | US20080124372 Morphology profiles for control of agent release rates from polymer matrices |
| 05/29/2008 | US20080124358 Chemically conjugating a peptide of interest to a heterologous peptide that has been expressed on the coat protein of a cowpea mosaic virus to generate a conjugate and administering the conjugate to a host animal to increase the level of TH1-type immune response |
| 05/29/2008 | US20080124347 Insulinotropic peptide conjugate using carrier substance |
| 05/29/2008 | US20080124346 Chimeric metal binding protein for use in prevention and treatment of cancer, diabetes, cardiovascular disease, obesity, metabolic disease, neurodegenerative disease, gastrointestinal disease, autoimmune disease, rheumatological disease and infectious disease. |
| 05/29/2008 | US20080124316 Use of hyaluronidase for prevention and treatment of cardiovascular diseases |
| 05/29/2008 | US20080124315 Method of reducing CRF receptor mRNA |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | DE102006054757A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 05/29/2008 | CA2670846A1 Pharmaceutical compositions for the treatment of capillary arteriopathy |
| 05/29/2008 | CA2670404A1 Heteromonocyclic compound and use thereof |
| 05/29/2008 | CA2670372A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2670340A1 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators |
| 05/29/2008 | CA2670223A1 Depsipeptides and their therapeutic use |
| 05/29/2008 | CA2670207A1 Process for preparing a crystalline form of candesartan cilexetil |
| 05/29/2008 | CA2670160A1 Methods for improving bioavailability of a renin inhibitor |
| 05/29/2008 | CA2669975A1 Ph.alpha.1b toxin, cdna of ph.alpha.1b toxin gene, pharmaceutical compositions containing ph.alpha.1b toxin, processes for their obtention and product |
| 05/29/2008 | CA2668828A1 Crystalline forms of aliskiren hemifumarate |
| 05/29/2008 | CA2666371A1 Use of an indazolemethoxyalkanoic acid to prepare a pharmaceutical composition |
| 05/29/2008 | CA2655310A1 Use of a2a adenosine receptor agonists in the treatment of ischemia |
| 05/28/2008 | EP1925617A1 Heterocyclic compound, and production process and use thereof |
| 05/28/2008 | EP1925303A2 Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure |
| 05/28/2008 | EP1924585A1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative |
| 05/28/2008 | EP1924326A1 Reducing myocardial damage and the incidence of arrhythmia arising from loss, reduction or interruption in coronary blood flow |
| 05/28/2008 | EP1924325A2 Pyridylsulfonamidyl-pyrimidines for the prevention of blood vessel graft failure |
| 05/28/2008 | EP1924259A2 Inhibition of intermediate-conductance calcium activated potassium channels in the treatment and/or prevention of atherosclerosis |
| 05/28/2008 | EP1863817B1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
| 05/28/2008 | EP1711177B1 1H-THIENO 2,3-c PYRAZOLE DERIVATIVES USEFUL AS KINASE I INHIBITORS |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1496898B1 Tyrosine kinase inhibitors |
| 05/28/2008 | EP1494992B1 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1425031B1 Hdl for the treatment of stroke and other ischemic conditions |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1368063B1 Complex of modafinil and cyclodextrin |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1313766B1 Coaster, a human coactivator of steroid receptors |
| 05/28/2008 | EP1307582B1 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | CN101189339A Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 05/28/2008 | CN101189236A Pyrazolo[1,5-a]pyridine derivatives or pharmaceutically acceptable salts thereof |
| 05/28/2008 | CN101189231A Novel cyclic aminophenylalkanoic acid derivative |
| 05/28/2008 | CN101189043A Use of adrenergic alpha2B antagonists for the treatment of vasomotor symptoms |
| 05/28/2008 | CN101186928A Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 05/28/2008 | CN101186923A CDNA sequence of coding perinereis albuhitensis grube protease and amino acid sequence thereof |
| 05/28/2008 | CN101186611A Pyrroline-2-one derivative capable of inhibiting cell to release tumor necrotic factor and its preparation and application |
| 05/28/2008 | CN101186596A Novel compound tatarine D and separating identification method thereof |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185752A Medicinal composition for treating heat failure and preparation method and application thereof |
| 05/28/2008 | CN101185709A Chinese herbal medicine for treating apoplexy sequelae (hemiparalysis) |
| 05/28/2008 | CN101185676A Ointment medicine for treating hemorrhoid |
| 05/28/2008 | CN101185669A Medicine composition for treating cardiovascular and cerebrovascular diseases |
| 05/28/2008 | CN101185665A Method for preparing total flavone of bidens bipinnata |
| 05/28/2008 | CN101185662A Method and use for preparing novel medicine for treating diabetes prepared from tuber fern |
| 05/28/2008 | CN101185659A Intermediate compound of a traditional Chinese medicinal preparation and preparation method and application thereof |
| 05/28/2008 | CN101185658A Intermediate compound of a liquid state traditional Chinese medicinal preparation and preparation method and application thereof |
| 05/28/2008 | CN101185653A Breviscapine oral administration composition and preparation method thereof |
| 05/28/2008 | CN101185647A Application of oxymatrine in preparing medicine for treating acute, chronic cardiac insufficiency disease |
| 05/28/2008 | CN101185646A Pharmaceutical compositions of amlodipine and atorvastatin |
| 05/28/2008 | CN101185643A Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 05/28/2008 | CN101185641A Atorvastatin calcium capsule and preparation method |
| 05/28/2008 | CN101185639A Alprostadil nano lipid carrier and preparation method thereof |
| 05/28/2008 | CN101185624A Novel composing prescription sustained-release preparation for treating high blood pressure and preparation method thereof |
| 05/28/2008 | CN101185619A Hemorrhoid-eliminating shower cream and preparation method |
| 05/28/2008 | CN101185506A Blood pressure reducing food and its preparation method |
| 05/28/2008 | CN100390540C Chinese medicine capsule for treating coronary heart clisease and angina pectoris, and quality control method |
| 05/28/2008 | CN100390203C Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods expecially for use as a plasma volume expander |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390174C Methylamino-pterin derivative with inhibiting nitric oxide synthetase function |
| 05/28/2008 | CN100390166C Benzopyran derivatives substituted with a benzimidazole derivative, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
| 05/28/2008 | CN100390164C Isoquinoline compounds and medicinal use thereof |
| 05/28/2008 | CN100390158C Novel theterocyclic analogs of diphenylethylene compounds |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/28/2008 | CN100389830C Medicinal composition for treating high blood pressure |
| 05/28/2008 | CN100389797C Medicine for treating piles and its preparing process |
| 05/28/2008 | CN100389795C Traditional Chinese medicine prepn. used for treating apoplexia and obstruction of qi in the chest, and its preparation method |
| 05/28/2008 | CN100389793C Medicinal composition of radix sal viae miltiorrhizae and radix puerariae for treating cardio-cerebro uascular disease and its preparing method |
| 05/28/2008 | CN100389789C Preparation method of capsule containing red sage root and notoginseng |
| 05/28/2008 | CN100389783C Extraction process of effective Chuanxiong component |
| 05/28/2008 | CN100389777C Moderate molecular weighted chondroitin sulfate injection and its preparing process |
| 05/28/2008 | CN100389773C Novel helicobacter pylori-binding substances and use thereof |
| 05/28/2008 | CN100389768C Milrinone composition for injection and its preparation process |